Yüklüyor......
The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive disease, with a median survival time of 2–5 years. The search for effective treatment has involved numerous clinical trials of investigational agents without significant success. However, in 2011, pirfenidone was the first drug to be approved for...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3643400/ https://ncbi.nlm.nih.gov/pubmed/23734908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-14-S1-S5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|